PharmaSil SRL
0.8 FTEThe score of PharmaSil shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaSil's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
PharmaSil's financial analysis
- Solvency37.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaSil
PharmaSil's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1007.715.677
- VAT number
- BE1007715677
- Peppol
- Registered · 0208:1007715677 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Mar 2024
- Registered office
- 2150 Antwerp
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
PharmaSil (SRL) has been based in Antwerp since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 133,126 € and equity of 241,248 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 37.2%, below the median of its sector (44.2%).
Companies similar to PharmaSil
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Melotte Retail sale of pharmaceutical products Oudsbergen · balance sheet 648,132 €
- Pharmacie N. Laforge Retail sale of pharmaceutical products Ans · balance sheet 648,431 €
- Corum Mariakerke Retail sale of pharmaceutical products Ghent · balance sheet 666,044 €
- Curavaleas Retail sale of pharmaceutical products Antwerp · balance sheet 650,626 €
- Francart-Delfosse Pharma Retail sale of pharmaceutical products Courcelles · balance sheet 645,104 €
- Daluphar Retail sale of pharmaceutical products Anderlecht · balance sheet 651,365 €
- RAF BEX Retail sale of pharmaceutical products Leuven · balance sheet 651,970 €
- J. Van Gyseghem Retail sale of pharmaceutical products Ninove · balance sheet 644,052 €
Frequently asked questions about PharmaSil
What is the revenue of PharmaSil?
PharmaSil files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of PharmaSil?
In Belgium, the VAT number is the company number prefixed with BE: BE1007715677 for PharmaSil, if the company is VAT-registered. Its company number (CBE) is 1007.715.677.
Where is the registered office of PharmaSil?
According to the CBE register, the registered office of PharmaSil is in 2150 Antwerp.
What is the equity of PharmaSil?
At the close of the 2025 financial year, the equity of PharmaSil amounts to 241,248 €, a solvency of 37.2% of total assets.
How many people work at PharmaSil?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages PharmaSil?
The register lists 1 active mandates at PharmaSil. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaSil
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →